INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Paragon 28, Inc. (NYSE: FNA); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel

Core Viewpoint - A class action lawsuit has been filed against Paragon 28, Inc. and certain executives for alleged violations of federal securities laws during the class period from May 5, 2023, to August 8, 2024 [1][5]. Group 1: Lawsuit Details - The lawsuit includes all individuals and entities that purchased or acquired Paragon 28 common stock, call options, or sold put options during the specified class period [1][2]. - Investors have until November 29, 2024, to seek appointment as lead plaintiff in the class action lawsuit [2]. Group 2: Allegations Against the Company - The lawsuit alleges that the defendants made materially false and misleading statements regarding Paragon 28's business operations and financial reporting, specifically understating costs and overstating inventories [5]. - The company announced on July 30, 2024, that its previously issued financial statements for the fiscal year ended December 31, 2023, and certain quarterly reports should no longer be relied upon due to errors, leading to a stock price drop of $1.24 per share, or 13.7% [6]. - On August 8, 2024, Paragon 28 filed amended financial reports that included restated figures, resulting in a further stock price decline of $1.67 per share, or 20% [7]. Group 3: Company Overview - Paragon 28 develops, distributes, and sells orthopedic surgical implants for foot and ankle procedures [4].